Lung Deposition of Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide Administered Via pMDI in Healthy, Asthmatic and COPD Patients

NCT02975843 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease
Asthma

Interventions

DRUG: Beclometasone dipropionate/Formoterol Fumarate/Glycopyrronium

Sponsor

Chiesi Farmaceutici S.p.A.